Association of Nasopharynx Cancer with Human Papillomavirus Infections
- PMID: 37627110
- PMCID: PMC10452438
- DOI: 10.3390/cancers15164082
Association of Nasopharynx Cancer with Human Papillomavirus Infections
Abstract
This population-based study aims to examine the association between nasopharyngeal carcinoma and human papillomavirus infections. This study included 2747 individuals aged 20 years and older who were diagnosed with nasopharynx cancer as cases and 13,735 propensity-score-matching controls. Multivariate logistic regression models were employed to quantitatively assess the association of nasopharynx cancer with human papillomavirus infections while considering age, sex, monthly income, geographic location, and urbanization level of the patient's residence as well as diabetes, hypertension, and hyperlipidemia. Our chi-squared test indicated a significant dissimilarity in previous human papillomavirus infection rates between nasopharynx cancer patients and controls (12.7% vs. 7.2%, p < 0.001). The adjusted odds ratio (OR) for prior human papillomavirus infections was found to be significantly higher for nasopharyngeal carcinoma cases compared to controls at a value of 1.869 with confidence interval ranging from 1.640 to 2.128. Among female participants, compared to controls, the adjusted OR of prior human papillomavirus infections was 2.150 (95% CI = 1.763-2.626) in patients with nasopharynx cancer. In male participants sampled in this study, we observed a statistically significant association between prior human papillomavirus infections and nasopharynx cancer (adjusted OR = 1.689; 95% CI = 1.421-2.008). Our study indicates a noteworthy association between previous human papillomavirus infections and nasopharyngeal carcinoma.
Keywords: epidemiology; human papillomavirus; human papillomavirus infection; nasopharyngeal carcinoma.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Nakanishi Y., Wakisaka N., Kondo S., Endo K., Sugimoto H., Hatano M., Ueno T., Ishikawa K., Yoshizaki T. Progression of understanding for the role of Epstein-Barr virus and management of nasopharyngeal carcinoma. Cancer Metastasis Rev. 2017;36:435–447. doi: 10.1007/s10555-017-9693-x. - DOI - PMC - PubMed
-
- Zhang Y., Fan J., Fan Y., Li L., He X., Xiang Q., Mu J., Zhou D., Sun X., Yang Y., et al. The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest. Clin. Epigenetics. 2018;10:26. doi: 10.1186/s13148-018-0459-2. - DOI - PMC - PubMed
-
- Raab-Traub N. Seminars in Cancer Biology. Elsevier; Amsterdam, The Netherlands: 2002. Epstein–Barr Virus in the Pathogenesis of NPC. - PubMed
-
- Dawson C.W., Port R.J., Young L.S. Seminars in Cancer Biology. Elsevier; Amsterdam, The Netherlands: 2012. The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC) - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
